0.00
Fusion Pharmaceuticals Inc (FUSN) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
100.00%
-
|
2.006 | 0.034 | 0.028 | 0.14 |
|
32.16%
28.27
|
21.39 | 26.75 | 24.88 | 24.56 |
Benefits Costs and Expenses |
96.18
|
- | - | - | 25.10 |
Costs And Expenses |
8.22%
23.15
|
21.39 | 26.75 | 24.88 | 25.10 |
Operating Income/Loss |
45.83%
-28.27
|
-19.39 | -26.71 | -24.86 | -24.42 |
Nonoperating Income/Loss |
26.11%
1.392
|
1.884 | 1.293 | 0.553 | -0.54 |
Income/Loss From Continuing Operations Before Tax |
4,895%
-96.18
|
2.006 | -25.18 | -24.29 | -24.96 |
Income Tax Expense/Benefit, Deferred |
430.73%
2.917
|
-0.882 | -0.696 | -0.494 | -0.651 |
Income Tax Expense/Benefit |
612.25%
1.296
|
-0.253 | -0.245 | -0.011 | -0.34 |
Income/Loss From Continuing Operations After Tax |
53.57%
-26.88
|
-17.50 | -25.42 | -24.30 | -26.45 |
|
63.34%
-28.18
|
-17.25 | -25.18 | -24.29 | -24.62 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
96.35%
2.5215
|
69.05 | 66.28 | 53.78 | 0.343 |
Diluted Average Shares |
96.35%
2.5215
|
69.05 | 66.28 | 53.78 | 0.343 |
Basic Earnings Per Share |
56.00%
-0.39
|
-0.25 | -0.38 | -0.45 | -0.55 |
Diluted Earnings Per Share |
56.00%
-0.39
|
-0.25 | -0.38 | -0.45 | -0.55 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):